ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study

Clara Carpeggiani1, Michele Coceani, Patrizia Landi

  • 1CNR Institute of Clinical Physiology, Pisa, Italy. clara@ifc.cnr.it

Atherosclerosis
|April 8, 2010
PubMed

Insights

Individuals with non-O blood groups face higher mortality risks from ischemic heart disease, especially younger women. Blood type may influence genetic screening and risk management for heart conditions.

Area of Science:

  • Cardiovascular Medicine
  • Genetics
  • Epidemiology

Background:

  • The ABO blood group system is a well-known human genetic trait.
  • Its association with cardiovascular diseases, particularly coronary heart disease (CHD), has been investigated with varying results.
  • Understanding these associations can inform risk stratification and management strategies.

Purpose of the Study:

  • To investigate the impact of ABO blood groups on risk factors, coronary artery involvement, and prognosis in patients with heart disease.
  • To analyze the distribution of ABO blood groups in a cohort of patients undergoing coronary angiography.
  • To determine if ABO blood type influences cardiac mortality and other adverse outcomes.

Main Methods:

  • An observational, single-center study included 4901 consecutive patients undergoing coronary angiography.
  • ABO blood group determination was performed for all participants.
  • Follow-up extended up to 10 years, with all-cause and cardiac death as primary endpoints.

Main Results:

  • The study population showed a different ABO blood group distribution compared to the general Italian population, with a higher proportion of non-O types.
  • Non-O blood groups were significantly associated with a family history of ischemic heart disease, hypercholesterolemia, and coronary atherosclerosis.
  • Patients with myocardial infarction showed a higher prevalence of A and B alleles. Non-O blood type was a predictor of cardiac mortality, particularly in younger patients and women.

Conclusions:

  • Non-O blood groups are linked to increased mortality in patients with ischemic heart disease.
  • The risk of cardiac death is elevated in non-elderly individuals, especially younger females, with non-O blood types.
  • ABO blood group determination could be valuable for genetic screening and personalized risk factor management in ischemic heart disease.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
The ABO Blood Group01:12

The ABO Blood Group

The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Blood Types02:20

Blood Types

Human blood is classified into different types based on the presence of antigens on the red blood cell's surface and antibodies in the plasma. Proper identification of blood type is essential for successful blood transfusion. The International Society of Blood Transfusion has identified 38 human blood types based on the surface antigens on the red blood cells. The most common types are ABO, Rh, and MNS blood types.
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...